India Diabetes: Curbing the surge of diabetes in India needs collaborative effort: Novo Nordisk CEO
Synopsis
Lars Fruergaard Jørgensen, the CEO of Novo Nordisk, the world’s largest producer of insulins, shares his thoughts on how to arrest the growing numbers of diabetes patients; the company’s blockbuster weight-loss drug Wegovy; regulating medicine prices; and more.
For Lars Fruergaard Jørgensen, CEO, Novo Nordisk, the world’s largest producer of insulins, India is a crucial market, amid the worrying uptrend in the reported number of cases of diabetics and pre-diabetics. Besides making medical treatment available and imparting training to nurses, he says, it is important that people in big cities change the way they live. From meals to giving up a sedentary lifestyle, everything needs to be reviewed
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Why ?
-
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
-
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
-
Clean experience with
Minimal Ads -
Comment & Engage with ET Prime community -
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise -
Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-